High-Throughput Next-Gen Live Cell Assays

A Portal and Merck HighRes Collaboration

Learn how Portal's integration with the HighRes PreciseDrop II (PDII) is transforming drug discovery—featuring real-world results from Merck.

What You'll Learn:

  • How Portal's in-line mechanoporation solution integrates with the HighRes PDII
  • Real-world implementation results from Merck's drug discovery workflows
  • Practical considerations for transitioning from biochemical to live-cell assays
  • Key applications: target engagement, DEL screening, PROTAC monitoring
  • Armon Sharei, Ph.D.

    Founder and CEO

  • Xi Ai

    Principal Scientist at Merck

  • Drew Glatczak

    Account Manager at HighRes Biosolutions